Status:

UNKNOWN

Doxycycline and Airway Inflammation in Chronic Obstructive Pulmonary Disease (COPD)

Lead Sponsor:

Medical Center Alkmaar

Collaborating Sponsors:

Leiden University Medical Center

University of Amsterdam

Conditions:

Chronic Obstructive Pulmonary Disease

Inflammation

Eligibility:

All Genders

41+ years

Phase:

PHASE4

Brief Summary

COPD is a progressive pulmonary disease that is characterized by an inflammatory process in the airways and the lungs which leads to progressive airway obstruction. The inflammation is associated with...

Detailed Description

Rationale: COPD is a disease characterized by chronic inflammation and irreversible airway obstruction. Chronic inflammation lead to degradation of extracellular matrix and hereby destruction of lung...

Eligibility Criteria

Inclusion

  • GOLD II or III COPD (GOLD II: FEV1/FVC \< 70%; 50% \< FEV1 \< 80% predicted, GOLD III: FEV1/FVC \< 70%; 30% \< FEV1 \< 50% predicted ).
  • Stable disease (no exacerbations in the last 3 months).
  • Age \> 40 yrs.
  • Written informed consent.

Exclusion

  • Infections and/or use of antibiotics in the last month.
  • Bacterial colonization of the airways, proven by sputum cultures or broncho-alveolar lavage (BAL).
  • Allergy for tetracyclines or a history of substantial side-effects.
  • Active respiratory diseases other than COPD (e.g. sarcoidosis, tuberculosis, lung cancer, bronchiectasis).
  • Acute exacerbation of COPD as defined by Anthonisen et al. \[10\].
  • Signs and/or symptoms of a current respiratory or non-respiratory infection.
  • Use of oral or intravenous corticosteroids or other immunosuppressive drugs within the last month.

Key Trial Info

Start Date :

April 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

January 1 2010

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT00857038

Start Date

April 1 2009

End Date

January 1 2010

Last Update

March 6 2009

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Medical Center Alkmaar

Alkmaar, North Holland, Netherlands, 1815JD